Literature DB >> 2118593

Association of transport-defective light chains with immunoglobulin heavy chain binding protein.

J Ma1, J F Kearney, L M Hendershot.   

Abstract

Immunoglobulin light chains are usually secreted from cells when they are synthesized alone or in molar excess of heavy chains, but, there have been reports of nonsecreted light chains. We wished to determine whether immunoglobulin heavy chain binding protein (BiP), which blocks the transport of free heavy chains, might be responsible for the lack of secretion of some light chains. In two murine lymphoid cell lines that synthesize but do not secrete immunoglobulin light chains, the free light chain polymers were found bound to BiP. Examination of 20 other cell lines and hybridomas failed to disclose any cells synthesizing free or excess light chains that associated with BiP, in all cases the free light chains were secreted as dimers. Despite their association with BiP and their blocked secretion, the aberrant light chains could combine with heavy chains and could be secreted as intact Ig molecules. Thus, while light chains do not usually express signals which allow them to bind to BiP, it appears that such signals can be expressed on certain light chains, resulting in their combination with BiP and blocked secretion. When single chain mutant cell lines are isolated from parental lines producing both heavy and light chains, they are almost always light chain producers suggesting that free heavy chains are much more toxic than free light chains. In both PC700 and P3X63Ag cells, however, clones that have lost either heavy chains or transport-defective light chains are present at the same frequency. Our findings that the light chains in both of these lines are associated with BiP raise the possibility that BiP actually contributes to heavy chain toxicity instead of preventing it.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118593     DOI: 10.1016/0161-5890(90)90004-j

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  BiP and immunoglobulin light chain cooperate to control the folding of heavy chain and ensure the fidelity of immunoglobulin assembly.

Authors:  Y K Lee; J W Brewer; R Hellman; L M Hendershot
Journal:  Mol Biol Cell       Date:  1999-07       Impact factor: 4.138

2.  Characterization of an ERAD pathway for nonglycosylated BiP substrates, which require Herp.

Authors:  Yuki Okuda-Shimizu; Linda M Hendershot
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

Review 3.  BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum.

Authors:  I G Haas
Journal:  Experientia       Date:  1994-11-30

4.  A shared endoplasmic reticulum-associated degradation pathway involving the EDEM1 protein for glycosylated and nonglycosylated proteins.

Authors:  Marina Shenkman; Bella Groisman; Efrat Ron; Edward Avezov; Linda M Hendershot; Gerardo Z Lederkremer
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

5.  Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion.

Authors:  Colleen M Doyle; Jiong Han; Martin G Weigert; Eline T Luning Prak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

6.  Members of the Hsp70 Family Recognize Distinct Types of Sequences to Execute ER Quality Control.

Authors:  Julia Behnke; Melissa J Mann; Fei-Lin Scruggs; Matthias J Feige; Linda M Hendershot
Journal:  Mol Cell       Date:  2016-08-18       Impact factor: 17.970

7.  Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae.

Authors:  Benjamin J Hackel; Dagang Huang; Jennifer C Bubolz; Xin X Wang; Eric V Shusta
Journal:  Pharm Res       Date:  2006-03-25       Impact factor: 4.200

8.  Interaction of BiP with newly synthesized immunoglobulin light chain molecules: cycles of sequential binding and release.

Authors:  M R Knittler; I G Haas
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

9.  Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains.

Authors:  J L Dul; D P Davis; E K Williamson; F J Stevens; Y Argon
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.